Starzl TE, Marchioro TL, VonKaulla KN, Hermann G, Brittain RS, Wadell WR (1963) Homotransplantation of the liver in humans. Surg Gynecol Obstet 117: 659–676
PubMed
CAS
Google Scholar
Neuberger J, Thorburn D (2005) Liver Transplantation Worldwide. Liver Transpl 11: 585–587
Article
Google Scholar
Child CG, Turcotte JG (1964) The liver and portal hypertension. In: Child CI (ed) Surgery and Portal Hypertension. W. B. Saunders, Philadelphia, USA, pp 50–58
Google Scholar
Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R (1973) Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60: 646–649
PubMed
CAS
Google Scholar
Cooper GS, Bellamy P, Dawson NV, Desbiens N, Fulkerson WJ Jr, Goldman L, Quinn LM, Speroff T, Landefeld CS (1997) A prognostic model for patients with end-stage liver disease. Gastroenterology 113: 1278–1288
PubMed
CAS
Article
Google Scholar
Fernandez-Esparrach G, Sanchez-Fueyo A, Gines P, Uriz J, Quinto L, Ventura PJ, Cardenas A, Guevara M, Sort P, Jimenez W, Bataller R, Arroyo V, Rodes J (2001) A prognostic model for predicting survival in cirrhosis with ascites. J Hepatol 34: 46–52
PubMed
CAS
Article
Google Scholar
Angermayr B, Koenig F, Cejna M, Karnel F, Gschwantler M, Ferenci P (2002) Creatinine-modified Child-Pugh score (CPSC) compared to MELD score to predict survival in patients undergoing TIPS. Hepatology 36: A860
Article
Google Scholar
Papatheodoridis GV, Cholongitas E, Dimitriadou E, Touloumi G, Sevastianos V, Archimandritis AJ (2005) MELD vs. Child-Pugh and creatinine-modified Child-Pugh score for predicting survival in patients with decompensated cirrhosis. World J Gastroenterol 11: 3099–3104
PubMed
Google Scholar
Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC (2000) A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 31: 864–871
PubMed
CAS
Article
Google Scholar
Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, D'Amico G, Dickson ER, Kim WR (2001) A model to predict survival in patients with end-stage liver disease. Hepatology 33: 464–470
PubMed
CAS
Article
Google Scholar
Christensen E (2004) Prognostic models including the Child-Pugh, MELD and Mayo risk scores—where are we and where should we go? J Hepatol 41: 344–350
PubMed
Article
Google Scholar
Wiesner RH, McDiarmid SV, Kamath PS, Edwards EB, Malinchoc M, Kremers WK, Krom RA, Kim WR (2001) MELD and PELD: application of survival models to liver allocation. Liver Transpl 7: 567–580
PubMed
CAS
Article
Google Scholar
Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, Kremers W, Lake J, Howard T, Merion RM, Wolfe RA, Krom R (2003) Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 124: 91–96
PubMed
Article
Google Scholar
Borroni G, Maggi A, Sangiovanni A, Cazzaniga M, Salerno F (2000) Clinical relevance of hyponatraemia for the hospital outcome of cirrhotic patients. Dig Liver Dis 32: 605–610
PubMed
CAS
Article
Google Scholar
Heuman DM, Abou-Assi SG, Habib A, Williams LM, Stravitz RT, Sanyal AJ, Fisher RA, Mihas AA (2004) Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. Hepatology 40: 802–810
PubMed
Article
Google Scholar
Ruf AE, Kremers WK, Chavez LL, Descalzi VI, Podesta LG, Villamil FG (2005) Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone. Liver Transpl 11: 336–343
PubMed
Article
Google Scholar
Trotter JF, Brimhall B, Arjal R, Phillips C (2004) Specific laboratory methodologies achieve higher model for endstage liver disease (MELD) scores for patients listed for liver transplantation. Liver Transpl 10: 995–1000
PubMed
Article
Google Scholar
Keeffe EB (1998) Summary of guidelines on organ allocation and patient listing for liver transplantation. Liver Transpl Surg 4: S108–S114
PubMed
CAS
Article
Google Scholar
O'Grady JG, Alexander GJ, Hayllar KM, Williams R (1989) Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 97: 439–445
PubMed
Google Scholar
Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabito A, Gennari L (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334: 693–699
PubMed
CAS
Article
Google Scholar
Freeman RB, Wiesner RH, Edwards E, Harper A, Merion R, Wolfe R (2004) Results of the first year of the new liver allocation plan. Liver Transpl 10: 7–15
PubMed
Article
Google Scholar
Freeman RB, Harper A, Edwards EB (2005) Excellent liver transplant survival rates under the MELD/PELD system. Transplant Proc 37: 585–588
PubMed
CAS
Article
Google Scholar
Kanwal F, Dulai GS, Spiegel BM, Yee HF, Gralnek IM (2005) A comparison of liver transplantation outcomes in the pre- vs. post-MELD eras. Aliment Pharmacol Ther 21: 169–177
PubMed
CAS
Article
Google Scholar
Coombes JM, Trotter JF (2005) Development of the allocation system for deceased donor liver transplantation. Clin Med Res 3: 87–92
PubMed
Article
Google Scholar
Freeman RB (2005) MELD: the holy grail of organ allocation? J Hepatol 42: 16–20
PubMed
Article
Google Scholar
Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabito A, Gennari L (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334: 693–699
PubMed
CAS
Article
Google Scholar
Graziadei IW, Sandmueller H, Waldenberger P, Koenigsrainer A, Nachbaur K, Jaschke W, Margreiter R, Vogel W (2003) Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome. Liver Transpl 9: 557–563
PubMed
Article
Google Scholar
Llovet JM, Burroughs A, Bruix J (2003) Hepatocellular carcinoma. Lancet 362: 1907–1917
PubMed
Article
Google Scholar
Sharma P, Balan V, Hernandez JL, Harper AM, Edwards EB, Rodriguez-Luna H, Byrne T, Vargas HE, Mulligan D, Rakela J, Wiesner RH (2004) Liver transplantation for hepatocellular carcinoma: the MELD impact. Liver Transpl 10: 36–41
PubMed
Article
Google Scholar
Berenguer M (2003) Host and donor risk factors before and after liver transplantation that impact HCV recurrence. Liver Transpl 9: S44–S47
PubMed
Article
Google Scholar
Freeman RB (2005) MELD: the holy grail of organ allocation? J Hepatol 42: 16–20
PubMed
Article
Google Scholar